OM Pharma SA

OM Pharma SA’s clinical research includes recurrent respiratory tract infections in young children, with attention to wheezing lower respiratory illness and infection-related respiratory morbidity.

• Recurrent respiratory tract infections
• Wheezing lower respiratory illness
• Paediatric respiratory disease

The sponsor’s studies in this area focus on childhood respiratory conditions where infection and wheezing overlap clinically.